RadioBDC Logo
Bombay Bicycle Club | RadioBDC: Celebrity Series Takeover Listen Live
THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING
By Beth Healy
Globe Staff / June 9, 2012
Text size +
  • E-mail
  • E-mail this article

    Invalid E-mail address
    Invalid E-mail address

    Sending your article

    Your article has been sent.

Vertex Pharmaceuticals Inc. said Friday that its chief legal officer and chief commercial officer are leaving the company. The Cambridge biotechnology company said its chief legal officer, Ty Howton, is leaving and will be replaced by Kenneth Horton, who will take the additional title of executive vice president and report directly to Vertex chief executive Jeffrey Leiden.

In addition, Nancy Wysenski, the company’s chief commercial officer, is retiring. Wysenski, 54, built the company’s first team to support the approval and launch of Vertex’s early medicines. A search is underway to fill her post, the company said.

For more from BostonGlobe.com, sign up or log in below

To continue, please sign up or log in to BostonGlobe.com

Access the full articles and quality reporting of The Boston Globe at BostonGlobe.com

Sign up

Unlimited Access to BostonGlobe.com for 4 weeks for only 99¢.

Are you a Boston Globe home delivery subscriber?

Get FREE access as part of your print subscription.

BostonGlobe.com subscriber

Click to continue reading this article or to log in to BostonGlobe.com.
  • E-mail
  • E-mail this article

    Invalid E-mail address
    Invalid E-mail address

    Sending your article

    Your article has been sent.